Visceral Adiposity, Not Abdominal Subcutaneous Fat Area, Is Associated With an Increase in Future Insulin Resistance in Japanese Americans
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Visceral adiposity is generally considered to play a key role in the metabolic syndrome. We sought to determine whether greater visceral adiposity directly measured by computed tomography (CT) is associated with increased future insulin resistance independent of other adipose depots. RESEARCH DESIGN AND METHODS— We followed 306 nondiabetic Japanese Americans over 10–11 years. Baseline variables included BMI; waist circumference; and abdominal, thoracic, and thigh fat areas measured by CT. Total fat area was estimated by the sum of all of these fat areas. Visceral adiposity was measured as intra-abdominal fat area at the umbilicus level. Total subcutaneous fat area was defined as total fat area minus intra-abdominal fat area. Insulin resistance was evaluated by homeostasis model assessment for insulin resistance (HOMA-IR), fasting plasma insulin level, Matsuda index, and area under the oral glucose tolerance test curve (AUC) of insulin. RESULTS— Both baseline intra-abdominal fat area (P = 0.002) and HOMA-IR (P < 0.001) were independently associated with increased HOMA-IR at 10–11 years in a multiple linear regression model after adjustment for abdominal subcutaneous fat area, age, sex, 2-h plasma glucose level, and incremental insulin response. Intra-abdominal fat area remained a significant predictor of increased HOMA-IR at 10–11 years even after adjustment for total subcutaneous fat area, total fat area, BMI, or waist circumference, but no other measure of CT-measured regional or total adiposity was significantly related with HOMA-IR at 10–11 years in models that contained intra-abdominal fat area. Similar results were obtained for predicting future fasting plasma insulin level, Matsuda index, and AUC of insulin. CONCLUSIONS— Greater visceral adiposity is associated with an increase in future insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These changes are associated with insulin resistance, as opposed to insulin-sensitive obesity, which is associated with proportionally more healthy subcutaneous fat cells and less visceral fat (8,13,14).”
From Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU) (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“The association between obesity and metabolic dysfunctions is predominantly dictated by fat distribution with increased visceral or intra-abdominal fat being more detrimental to metabolic health compared to peripheral adiposity depots, which appear to confer a better metabolic profile (Vazquez et al., 2007; Hayashi et al., 2008; Castro et al., 2014).”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Hayashi et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 2×
“The homeostasis model assessment for insulin resistance (HOMA-IR) was developed to serve as a surrogate measure of insulin resistance that only requires assessment of basal glucose and insulin concentrations (8), and it, along with fasting plasma insulin, has frequently been used in epidemiological studies to assess i…”
BackgroundMethodReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 3×
“The purpose of this study was to determine whether greater visceral adiposity directly measured by computed tomography (CT) was associated independent of other adipose depots, with a future increase in insulin resistance as assessed by multiple measures, including HOMA-IR, fasting plasma insulin, the Matsuda index, an…”
BackgroundUse and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 2×
“The homeostasis model assessment for insulin resistance (HOMA-IR) was developed to serve as a surrogate measure of insulin resistance that only requires assessment of basal glucose and insulin concentrations (8), and it, along with fasting plasma insulin, has frequently been used in epidemiological studies to assess i…”
MethodSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Adipocytederived proteins may also play a key role in the pathogenesis of peripheral insulin resistance (28).”
BackgroundRothman, K. J., Greenland, S., & Lash, T. L. (1998) · Cited by 2,096
New Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · cited 1×
“For instance, levels of the insulin-sensitizing adipocyte-derived protein adiponectin are reported to be positively related with insulin sensitivity (29).”
BackgroundSelf-citationPrimer of Applied Regression & Analysis of Variance
Glantz, S. A., & Slinker, B. K. (1990) · UCLA - Biblioteca de Ciencias y Tecnologia Felix Morales Bueno · Cited by 1,189
Cited by
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Gluteofemoral body fat as a determinant of metabolic health
Manolopoulos, K. N., Karpe, F., & Frayn, K. N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.286 · Cited by 811
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500
Self-citationPreis, S. R., Massaro, J. M., Robins, S. J., Hoffmann, U., Vasan, R. S., Irlbeck, T., Meigs, J. B., Sutherland, P., D'Agostino Sr, R. B., O'Donnell, C. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.59 · Cited by 412
Physical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology
Thompson, D., Karpe, F., Lafontan, M., & Frayn, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00012.2011 · Cited by 402
“Longitudinal studies of the development of insulin resistance in Japanese Americans suggest that the visceral fat depot has a particularly adverse role (89), but visceral and subcutaneous depots are highly correlated in cross-sectional studies (64), making it very difficult to disentangle these relationships to health.”
BackgroundMetformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
“These changes are associated with insulin resistance, as opposed to insulin-sensitive obesity, which is associated with proportionally more healthy subcutaneous fat cells and less visceral fat (8,13,14).”
BackgroundSergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Obesity, insulin resistance and comorbidities? Mechanisms of association
Castro, A. V. B., Kolka, C. M., Kim, S. P., & Bergman, R. N. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003223 · Cited by 254
Palaniappan, L. P., Araneta, M. R. G., Assimes, T. L., Barrett-Connor, E. L., Carnethon, M. R., Criqui, M. H., Fung, G. L., Narayan, K. M. V., Patel, H., Taylor-Piliae, R. E., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181f22af4 · Cited by 241
Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S.
Ausk, K. J., Boyko, E. J., & Ioannou, G. N. (2010) · Diabetes Care · doi:10.2337/dc09-2110 · Cited by 162
“Obesity is known to be a strong risk factor for insulin resistance, in particular ectopic as opposed to subcutaneous adiposity (10).”
BackgroundSelf-citationHow the association between obesity and inflammation may lead to insulin resistance and cancer
Amin, M. N., Hussain, M. S., Sarwar, M. S., Moghal, M. M. R., Das, A., Hossain, M. Z., Chowdhury, J. A., Millat, M. S., & Islam, M. S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.041 · Cited by 165
Smith, J. D., Borel, A.-L., Nazare, J.-A., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J.-P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2550 · Cited by 148
de Mutsert, R., Gast, K. B., Widya, R. L., de Koning, E. J. P., Jazet, I. M., Lamb, H. J., le Cessie, S., Roos, A., Smit, J. W. A., Rosendaal, F. R., et al. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0128 · Cited by 160
“8,13 In the IRAS study SAT, and not VAT, was associated with acute insulin response as assessed with an intravenous glucose tolerance test.”
InfluentialBandera, E. V., Maskarinec, G., Romieu, I., & John, E. M. (2015) · Advances in Nutrition · doi:10.3945/an.115.009647 · Cited by 148
“Visceral adipose tissue plays an important role in lipid and glucose metabolism due to the production of various hormones and cytokines (118) and is more strongly associated with an adverse metabolic risk profile than subcutaneous fat, even after controlling for standard anthropometric indexes (119).”
BackgroundMakimura, H., Stanley, T., Mun, D., You, S. M., & Grinspoon, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1333 · Cited by 118
Yim, J. Y., Kim, D., Lim, S. H., Park, M. J., Choi, S. H., Lee, C. H., Kim, S. S., & Cho, S.-H. (2010) · Diabetes Care · doi:10.2337/dc10-0606 · Cited by 115
“Several studies have suggested that, compared to subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) has a stronger correlation to these obesity-related disorders (3,4).”
BackgroundThe Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus
Han, S. J., & Boyko, E. J. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0055 · Cited by 112
“Previous research suggests that the fat distribution pattern has a greater influence on cardiometabolic risk than BMI [47,48].”
BackgroundSelf-citationObesity-Related Digestive Diseases and Their Pathophysiology
Nam, S. Y. (2016) · Gut and Liver · doi:10.5009/gnl15557 · Cited by 113
“80 Abdominal obesity is associated with BE and EAC (OR, 2.51).81 A recent Mendelian randomized study using 999 patients with EAC, 2,061 patients with BE, and 2,169 population controls demonstrated that EAC and BE risk increased by 16% (OR, 1.16) and 12% (OR, 1.12) per 1 kg/m2 increase in BMI.82 Obesity increased intra…”
BackgroundInfluentialHeterogeneity of Diabetes Outcomes Among Asians and Pacific Islanders in the U.S.
Kanaya, A. M., Adler, N., Moffet, H. H., Liu, J., Schillinger, D., Adams, A., Ahmed, A. T., & Karter, A. J. (2011) · Diabetes Care · doi:10.2337/dc10-1964 · Cited by 101
“We did not measure waist circumference, which may be a better indicator of adiposity in Asians (24).”
BackgroundDietary Patterns and Risk for Diabetes
Erber, E., Hopping, B. N., Grandinetti, A., Park, S.-Y., Kolonel, L. N., & Maskarinec, G. (2010) · Diabetes Care · doi:10.2337/dc09-1621 · Cited by 100
Diabetes Incidence Based on Linkages With Health Plans: The Multiethnic Cohort
Maskarinec, G., Erber, E., Grandinetti, A., Verheus, M., Oum, R., Hopping, B. N., Schmidt, M. M., Uchida, A., Juarez, D. T., Hodges, K., et al. (2009) · Diabetes · doi:10.2337/db08-1685 · Cited by 98
“As shown in Japanese studies, visceral fat is a risk factor for insulin resistance (11,12) and central obesity confers a higher diabetes risk than overall adiposity (28).”
BackgroundHuman obesity relationship with Ad36 adenovirus and insulin resistance
Trovato, G. M., Castro, A., Tonzuso, A., Garozzo, A., Martines, G. F., Pirri, C., Trovato, F. M., & Catalano, D. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.196 · Cited by 92
“Central obesity has been reported to correlate strongly with I”
Abdominal Visceral Adipose Tissue Predicts Risk of Colorectal Adenoma in Both Sexes
Nam, S. Y., Kim, B. C., Han, K. S., Ryu, K. H., Park, B. J., Kim, H. B., & Nam, B. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.02.001 · Cited by 91
Oka, R., Miura, K., Sakurai, M., Nakamura, K., Yagi, K., Miyamoto, S., Moriuchi, T., Mabuchi, H., Koizumi, J., Nomura, H., et al. (2010) · Obesity · doi:10.1038/oby.2009.180 · Cited by 85
“Moreover, some prospective studies have identified VAT as being predictive of future insulin resistance (23) and other features of metabolic syndrome (14,20,24), indicating that an excess of VAT may precede the development of metabolic disorders.”
BackgroundWald, D., Teucher, B., Dinkel, J., Kaaks, R., Delorme, S., Boeing, H., Seidensaal, K., Meinzer, H., & Heimann, T. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23775 · Cited by 80
O'Connor, M. Y., Thoreson, C. K., Ricks, M., Courville, A. B., Thomas, F., Yao, J., Katzmarzyk, P. T., & Sumner, A. E. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0026 · Cited by 88
“21 In addition, we found that African immigrants had lower AIRg and DI values than African Americans, despite similar S I values.”
Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome
Pant, R., Firmal, P., Shah, V. K., Alam, A., & Chattopadhyay, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619888 · Cited by 91
Sreedharan, S., Gokulakrishnan, K., Velmurugan, K., Deepa, M., & Mohan, V. (2010) · PubMed · Cited by 77
Des‐acyl ghrelin analogs prevent high‐fat‐diet‐induced dysregulation of glucose homeostasis
Delhanty, P. J. D., Huisman, M., Baldeon‐Rojas, L. Y., van den Berge, I., Grefhorst, A., Abribat, T., Leenen, P. J. M., Themmen, A. P. N., & van der Lely, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-221143 · Cited by 72
Mirmiran, P., Bahadoran, Z., & Azizi, F. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.443 · Cited by 72
van Kruijsdijk, R. C. M., van der Graaf, Y., Peeters, P. H. M., Visseren, F. L. J., & on behalf of the Second Manifestations of ARTerial disease (SMART) study group (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0090 · Cited by 76
“grade inflammation (39, 40) and VAT might therefore be a better determinant for certain cancers than BMI or waist circumference, as the latter measures are known to misclassify individuals in terms of VAT and metabolic risk (41).”
BackgroundLiu, L., Feng, J., Zhang, G., Yuan, X., Li, F., Yang, T., Hao, S., Huang, D., Hsue, C., & Lou, Q. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1364226 · Cited by 77
Nagata, N., Sakamoto, K., Arai, T., Niikura, R., Shimbo, T., Shinozaki, M., Aoki, T., Kishida, Y., Sekine, K., Tanaka, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28872 · Cited by 74
“WC and WHR are nonspecific measures of abdominal fat and mainly reflect the distribution of body fat in the abdomen without distinguishing between visceral and subcutaneous fat.27 Moreover, direct measurement of VAT by CT is a better predictor of insulin resistance than WC and BMI.28 Although routine use of CT is not…”
BackgroundInfluentialJain, S. K., Kahlon, G., Morehead, L., Dhawan, R., Lieblong, B. J., Stapleton, T., Caldito, G. C., Hoeldtke, R. D., Levine, S. N., & Bass, P. F. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100719 · Cited by 75
Schwenzer, N. F., Machann, J., Schraml, C., Springer, L., Ludescher, B., Stefan, N., Häring, H. U., Fritsche, A., Claussen, C. D., & Schick, F. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181f10fe1 · Cited by 71
Association of Visceral Fat and Liver Fat With Hyperuricemia
Yamada, A., Satō, K., Kinuhata, S., Uehara, S., Endo, G., Hikita, Y., Fujimoto, W. Y., Boyko, E. J., & Hayashi, T. (2015) · Arthritis Care & Research · doi:10.1002/acr.22729 · Cited by 62
Self-citationPerirenal Fat and Association With Metabolic Risk Factors
Roever, L., Resende, E. S., Veloso, F. C., Diniz, A. L. D., Penha‐Silva, N., Casella–Filho, A., Dourado, P. M. M., & Chagas, A. C. P. (2015) · Medicine · doi:10.1097/md.0000000000001105 · Cited by 60
Yaturu, S. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.14012 · Cited by 88
Correlates of insulin resistance in older individuals with and without kidney disease
Landau, M. S., Tamura, M. K., Shlipak, M. G., Kanaya, A. M., Strotmeyer, E. S., Koster, A., Satterfield, S., Simsonick, E., Goodpaster, B. H., Newman, A. B., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq817 · Cited by 59
Oh, Y. H., Moon, J. H., Kim, H. J., & Kong, M. H. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s150914 · Cited by 58
Risk factors for type 2 diabetes: Lessons learned from Japanese Americans in Seattle
Fujimoto, W. Y., Boyko, E. J., Hayashi, T., Kahn, S. E., Leonetti, D. L., McNeely, M. J., & Shuman, W. P. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00195.x · Cited by 60
Self-citationSasai, H., Brychta, R. J., Wood, R. P., Rothney, M. P., Zhao, X., Skarulis, M. C., & Chen, K. Y. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815577424 · Cited by 57
Doumatey, A. P., Lashley, K., Huang, H., Zhou, J., Chen, G., Amoah, A. G. B., Agyenim‐Boateng, K., Oli, J., Fasanmade, O. A., Adebamowo, C., et al. (2009) · Obesity · doi:10.1038/oby.2009.322 · Cited by 55
The AdipoChaser mouse: A model tracking adipogenesis in vivo
Wang, Q. A., & Scherer, P. E. (2014) · Adipocyte · doi:10.4161/adip.27656 · Cited by 54
Haufe, S., Engeli, S., Budziarek, P., Utz, W., Schulz‐Menger, J., Hermsdorf, M., Wiesner, S., Otto, C., Haas, V. K., de Greiff, A., et al. (2010) · Diabetes · doi:10.2337/db09-1200 · Cited by 62
“In previous studies, abdominal fat area was measured from a single-slice computed tomography scan at the level of the fourth or fifth vertebra (8,10,11,24,25) or the umbilicus (26).”
HOMA-IR and the risk of hyperuricemia: A prospective study in non-diabetic Japanese men
Nakamura, K., Sakurai, M., Miura, K., Morikawa, Y., Nagasawa, S., Ishizaki, M., Kido, T., Naruse, Y., Nakashima, M., Nogawa, K., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.006 · Cited by 49
“[32] Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.”
BackgroundNakao, Y. M., Miyawaki, T., Yasuno, S., Nakao, K., Tanaka, S., Ida, M., Hirata, M., Kasahara, M., Hosoda, K., Ueshima, K., et al. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.454 · Cited by 62
The obesity paradox and diabetes
Gravina, G., Ferrari, F., & Nebbiai, G. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-01015-1 · Cited by 56
Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance
Han, S. J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & Leonetti, D. L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01703 · Cited by 50
Self-citationPark, J. S., Cho, M. H., Ahn, C. W., Kim, K. R., & Huh, K. B. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-62 · Cited by 46
“Obesity, especially abdominal obesity, may play a major role in insulin resistance and various metabolic risk factors [2-6], however, recent studies have suggested that body muscle mass is also related to insulin resistance [1,7].”
BackgroundPrevalence of Pancreatic Cystic Lesions Is Associated With Diabetes Mellitus and Obesity
Mizuno, S., Isayama, H., Nakai, Y., Yoshikawa, T., Ishigaki, K., Matsubara, S., Yamamoto, N., Ijichi, H., Tateishi, K., Tada, M., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000833 · Cited by 47
“Another limitation was the lack of data on VAT, which is strongly associated with insulin resistance.(34) Body mass index and waist circumference are good surrogate markers for VAT,(35) but our speculation regarding the association between insulin resistance and PCLs should be investigated further.”
BackgroundKim, H.-N., & Song, S.-W. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9934-6 · Cited by 44
Abdominal obesity and insulin resistance after an episode of acute pancreatitis
Singh, R. G., Pendharkar, S. A., Cervantes, A., Cho, J., Miranda-Soberanis, V., & Petrov, M. S. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.04.023 · Cited by 43
Leptin, Adiponectin, and Obesity among Caucasian and Asian Women
Conroy, S. M., Chai, W., Lim, U., Franke, A. A., Cooney, R. V., & Maskarinec, G. (2011) · Mediators of Inflammation · doi:10.1155/2011/253580 · Cited by 50
“Particularly, a higher proportion of abdominal visceral relative to subcutaneous adiposity among Asians than Caucasians [4, 5] may be responsible for insulin resistance and other adverse metabolic health effects [6, 7].”
BackgroundTsou, M.-T., Chang, Y., Hsu, C.-P., Kuo, Y., Yun, C., Huang, W.-H., Hu, K., Liu, C., Chen, Y., Sung, K., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00608-6 · Cited by 50
Endocannabinoid signaling and energy metabolism: A target for dietary intervention
Kim, J. J., Li, Y., & Watkins, B. A. (2011) · Nutrition · doi:10.1016/j.nut.2010.11.003 · Cited by 49
“Because insulin sensitivity correlates negatively with the degree of adiposity [80], the SR141716induced weight loss may contribute to the improvement of glucose homeostasis.”
BackgroundKoh, H., Hayashi, T., Satō, K., Harita, N., Maeda, I., Nishizawà, Y., Endo, G., Fujimoto, W. Y., Boyko, E. J., & Hikita, Y. (2011) · Hypertension Research · doi:10.1038/hr.2010.271 · Cited by 41
Self-citationDiagnosis criteria for obesity and obesity disease
Ogawa, W., & Miyazaki, S. (2015) · Health Evaluation and Promotion · doi:10.7143/jhep.42.301 · Cited by 38
Single-slice epicardial fat area measurement: do we need to measure the total epicardial fat volume?
Oyama, N., Goto, D., Ito, Y. M., Ishimori, N., Mimura, R., Furumoto, T., Kato, F., Tsutsui, H., Tamaki, N., Terae, S., et al. (2011) · Japanese Journal of Radiology · doi:10.1007/s11604-010-0524-z · Cited by 39
Plasma dihydroceramide species associate with waist circumference in Mexican American families
Mamtani, M., Meikle, P. J., Kulkarni, H. R., Weir, J. M., Barlow, C. K., Jowett, J. B. M., Bellis, C., Dyer, T. D., Almasy, L. A., Mahaney, M. C., et al. (2013) · Obesity · doi:10.1002/oby.20598 · Cited by 40
“(12) Waist circumference is strongly associated with visceral rather than subcutaneous fat (13, 14, 15, 16) as well as commonly used clinical indexes of lipemic status like total serum cholesterol, serum triglycerides and serum high-density lipoprotein (HDL) cholesterol.”
BackgroundPelclová, J., Gába, A., Tlučáková, L., & Pośpiech, D. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.06.014 · Cited by 46
Saito, T., Nishida, M., Saito, M., Tanabe, A., Eitsuka, T., Yuan, S.-H., Ikekawa, N., & Nishida, H. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.09.004 · Cited by 38
Matsushita, Y., Nakagawa, T., Yamamoto, S., Takahashi, Y., Yokoyama, T., Mizoue, T., & Noda, M. (2012) · Diabetes Care · doi:10.2337/dc11-1320 · Cited by 38
Kim, J. H., Bo, Y. H., Hong, E. S., Ohn, J. H., Kim, C. H., Kim, H. W., Ahn, H. Y., Yoon, J. W., Kang, S. M., Park, Y. J., et al. (2010) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2010.14.3.121 · Cited by 35
Mure, K., MAEDA, S., Mukoubayashi, C., Mugitani, K., Iwane, M., Kinoshita, F., Mohara, O., & Takeshita, T. (2013) · Nutrition · doi:10.1016/j.nut.2013.01.011 · Cited by 33
Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians
Abate, N. I., & Chandalia, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.046 · Cited by 41
Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study
Satō, K., Hayashi, T., Maeda, I., Koh, H., Harita, N., Uehara, S., Onishi, Y., Oue, K., Nakamura, Y., Endo, G., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12171 · Cited by 33
Self-citationSteinbrecher, A., Erber, E., Grandinetti, A., Nigg, C., Kolonel, L. N., & Maskarinec, G. (2012) · Journal of Physical Activity and Health · doi:10.1123/jpah.9.5.634 · Cited by 32
Richey, J. M., Woolcott, O. O., Stefanovski, D., Harrison, L. N., Zheng, D., Lottati, M., Hsu, I. R., Kim, S. P., Kabir, M., Catalano, K. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90972.2008 · Cited by 32
“Increased fat accumulation in the abdomen, particularly visceral adiposity, has been associated with a variety of metabolic abnormalities, including insulin resistance and cardiovascular diseases (4, 14, 30, 42, 44).”
BackgroundKim, J. E., Dunville, K., Li, J., Cheng, J., Conley, T. B., Couture, C. S., & Campbell, W. W. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.257 · Cited by 36
Plasma sphingomyelins increase in pre-diabetic Korean men with abdominal obesity
Im, S., Park, H. Y., Shon, J. C., Chung, I., Cho, H., Liu, K., & Song, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213285 · Cited by 31
Smoking inhibits visceral fat accumulation in Turkish women
Onat, A., Ayhan, E., Hergenç, G., Can, G., & Barlan, M. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.029 · Cited by 31
“Increased insulin resistance was predicted prospectively also by greater visceral adiposity at baseline among 306 Japanese Americans independently of abdominal adipose tissues [20].”
BackgroundYu, P., Huang, T., Hu, S., & Yu, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038420 · Cited by 34
Ye, Y., Bao, Y., Hou, X., Pan, X., Wu, H., Li, H., Wang, C., Tang, J., Lu, H., Xiang, K., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.134 · Cited by 30
Vanin 1 Gene Role in Modulation of iNOS/MCP-1/TGF-β1 Signaling Pathway in Obese Diabetic Patients
Mosaad, Y. O., Hussein, M. A., Ateyya, H., Mohamed, A., Ali, A., Youssuf, A. R., Wink, M., & El-Kholy, A. A.-E. S. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s386506 · Cited by 33
Asian Ethnicity is Associated With a Higher Trunk/Peripheral Fat Ratio in Women and Adolescent Girls
Morimoto, Y., Maskarinec, G., Conroy, S. M., Lim, U., Shepherd, J., & Novotny, R. (2012) · Journal of Epidemiology · doi:10.2188/jea.je20110100 · Cited by 29
Zheng, L., Sun, A., Han, S., Qi, R., Wang, R., Gong, X., & Xue, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1249401 · Cited by 34
Heianza, Y., Arase, Y., Fujihara, K., Tsuji, H., Saito, K., Hsieh, S. D., Kodama, S., Shimano, H., Yamada, N., Hara, S., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03667.x · Cited by 30
Lim, S. K., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Cho, N. H., Shin, H., Park, K. S., et al. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.07.013 · Cited by 30
“Along with these studies, the clustering of non-adipose components of MetS was commonly used to determine optimal WC cut points (Zhu et al., 2002; Hara et al., 2006; Hayashi et al., 2008; Oka et al., 2008).”
MethodCron, D. C., Noon, K. A., Cote, D. R., Terjimanian, M. N., Augustine, J. J., Wang, S. C., Englesbe, M. J., & Woodside, K. J. (2017) · Clinical Transplantation · doi:10.1111/ctr.13040 · Cited by 29
Premanath, M., Basavanagowdappa, H., Mahesh, M., & Suresh, M. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.139231 · Cited by 29
Matsushita, Y., Nakagawa, T., Yamamoto, S., Takahashi, Y., Yokoyama, T., Mizoue, T., & Noda, M. (2013) · Obesity · doi:10.1002/oby.20347 · Cited by 30
Yu, D., Huang, J., Hu, D., Chen, J., Cao, J., & Li, J. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.008 · Cited by 27
Sasaki, R., Yano, Y., Yasuma, T., Onishi, Y., Suzuki, T., Maruyama-Furuta, N., Gabazza, E. C., Sumida, Y., & Takei, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4100 · Cited by 30
Kurhe, Y., & Mahesh, R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.004 · Cited by 32
Ibrahim, Q., & Ahsan, M. (2019) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2019.168.173 · Cited by 41
Lu, Y., Yang, H. J., Xu, Z., & Tang, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s309400 · Cited by 30
Kim, H.-N., Song, S.-W., & Choi, W.-S. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.006 · Cited by 27
Associations between obesity, metabolic health, and the risk of breast cancer in East Asian women
Park, B., Kim, S., Kim, H., Cha, C., & Chung, M. S. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01540-5 · Cited by 30
“Insulin resistance and central obesity are suggested to be the main factors in the pathogenesis of MetS [30, 31].”
BackgroundBu, J., Feng, Q., Ran, J., Li, Q., Mei, G., & Zhang, Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.014 · Cited by 25
“[11] Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.”
BackgroundResultMunetsuna, E., Yamada, H., Ando, Y., Yamazaki, M., Tsuboi, Y., Kondo, M., Mizuno, G., Ishikawa, H., Sugimoto, K., Osakabe, K., et al. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217735124 · Cited by 21
Kim, N. H., Kim, K. J., Choi, J., & Kim, S. G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154894 · Cited by 25
“Given the close association of VAT with insulin resistance, and further with metabolic syndrome, this parameter could be a determinant of the metabolic health status at a given BMI [24].”
Gender differences of visceral fat area for predicting incident type 2 diabetes in Koreans
Kim, E. H., Kim, H., Bae, S., Lee, M. J., Hwang, J. Y., Choe, J., Jung, C. H., Lee, W. J., & Park, J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.020 · Cited by 23
Han, Y., Ma, Y., Liu, Y., Zhao, Z., Zhen, S., Yang, X., Xu, Z., & Wen, D. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s201594 · Cited by 21
Juan, H., Lin, H., Chou, Y., Yang, Y., Shih, P. M., Chuang, S., Shen, J.-T., & Juan, Y. (2012) · European Radiology · doi:10.1007/s00330-012-2413-6 · Cited by 21
“Several studies have shown that VFA, but not SFA, correlates with the severity of metabolic syndrome [21–23].”
BackgroundLee, J., FREELAND-GRAVES, J. H., Pepper, M. R., Yu, W., & Xu, B. (2015) · American Journal of Human Biology · doi:10.1002/ajhb.22663 · Cited by 25
“…depot because of its associations with escalated risks of cardiovascular disease, diabetes, and metabolic syndrome; whereas, subcutaneous adipose tissue is linked with lower health risks (Despres and Lemieux, 2006; Despres et al., 2008; Fox et al., 2007; Hayashi et al., 2008; Preis et al., 2010).”
BackgroundDisparity in Diabetes Risk Across Native Hawaiians and Different Asian Groups
Maskarinec, G., Jacobs, S., Morimoto, Y., Chock, M., Grandinetti, A., & Kolonel, L. N. (2014) · Asia Pacific Journal of Public Health · doi:10.1177/1010539514548757 · Cited by 20
Wander, P. L., Hayashi, T., Satō, K., Uehara, S., Hikita, Y., Leonetti, D. L., Kahn, S. E., Fujimoto, W. Y., & Boyko, E. J. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.004 · Cited by 22
Self-citation
Metadata
- Authors
- Hayashi, T., Boyko, E. J., McNeely, M. J., Leonetti, D. L., Kahn, S. E., & Fujimoto, W. Y.
- Affiliations
- Osaka City University (JP)
- University of Washington (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-05-01
- Volume
- 57
- Issue
- 5
- Pages
- 1269-1275
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2103410011
- Semantic Scholar
- 22bd8941bcf724a743d4b0c8c19f3b0046c5b082
- Cited by
- 207
- References
- 40
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 13 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 18
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- U.S. Department of Veterans Affairs
- University of Washington (DK17047, DK-35816, RR-00037)
- National Institutes of Health (DK-31170)
- National Heart, Lung, and Blood Institute (HL 49293, R01HL049293)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, DK 31170, K24DK002654, DK 02654, DK-17047, P30DK035816, P30DK017047)
- National Center for Research Resources (RR00037)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- visceral fat, insulin resistance, intra-abdominal fat, subcutaneous abdominal fat, regional adiposity, metabolic syndrome, Japanese Americans, HOMA-IR, fasting insulin, Matsuda index, insulin sensitivity
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Female, Follow-Up Studies, Humans, Insulin, Insulin Resistance, Inulin, Japan, Male, Middle Aged, United States, Viscera, Area Under Curve, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.